These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3004017)

  • 1. Effect of the oral administration of NIVGRIP inactivated influenza vaccine on virus carriage in the nasopharynx of children aged 0-5 years.
    Isaia G; Teodosiu O; Athanasiu P; Petrescu A; Dumitrescu G
    Virologie; 1985; 36(4):269-72. PubMed ID: 3004017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharyngeal viral population in 3- to 6-year-old children before and after influenza immunization using the NIVGRIP vaccine administered orally].
    Pârvu C; Petrescu A; Coban V
    Virologie; 1986; 37(4):263-7. PubMed ID: 3548031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of viruses in the nasopharynx of apparently healthy children aged 0-5 years. Results of investigations performed in 1982-83.
    Isaia G; Teodosiu O; Popescu G; Athanasiu P; Sternberg I; Dumitriu Z
    Virologie; 1985; 36(3):175-9. PubMed ID: 3000066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of the NIVGRIP inactivated influenza vaccine applied by oral route: evaluation in a community of pre-school children in the period 1981-84.
    Coban V; Mihail A; Petrescu A; Teodosiu O; Sternberg I
    Virologie; 1985; 36(2):79-83. PubMed ID: 4036003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results obtained with the NIVGRIP inactivated influenza vaccine applicable by nasal and/or oral route.
    Petrescu AL; Cajal N
    Virologie; 1984; 35(4):307-14. PubMed ID: 6516213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM; Yi T; Ambrose CS
    Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The virological study of a certified focus of acute respiratory diseases in a half-closed community].
    Steiner N; Mihail A; Berca C; Călina A
    Rev Roum Virol; 1990; 41(3-4):209-11. PubMed ID: 2099831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of influenza vaccination on the circulation of viruses in the respiratory tract of apparently healthy schoolchildren aged 7 to 14 years.
    Isaia G; Teodosiu O; Popescu G; Broniţki A; Sternberg I
    Virologie; 1982; 33(2):117-22. PubMed ID: 6293163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of immunization with an inactivated influenza vaccine, NIVGRIP, on the viral population and clinical course of patients with chronic non-bacterial pharyngitis].
    Isaia G; Athanasiu P; Teodosiu O; Anghelescu S; Isaia C; Petrescu A
    Virologie; 1987; 38(2):95-101. PubMed ID: 3039727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of neutralizing secretory influenza antibodies after nasal administration of the NIVGRIP trivalent influenza vaccine.
    Petrescu A; Steiner N; Trăilescu G; Teodosiu O; Mihăilescu M; Berca C
    Virologie; 1985; 36(3):187-94. PubMed ID: 4071977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The 1985 influenza epidemic in a pediatric practice].
    Döller G; Tjhen KY; Döller PC; Gerth HJ
    Monatsschr Kinderheilkd; 1987 Apr; 135(4):197-9. PubMed ID: 3600670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing the safety and effectiveness of oral administration of a live influenza vaccine.
    Aleksandrova GI; Smorodintsev AA; Beljaeva NM; Vasil'ev BJ; Geft RA; Panteleev VG; Sejfer MA; Selivanov AA
    Bull World Health Organ; 1970; 42(3):429-36. PubMed ID: 5310592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.
    Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M
    J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complex studies of virology, microbiology, biochemistry and epidemiology in the adults of a semi-closed community vaccinated against influenza with the inactivated NIVGRIP vaccine intranasally].
    Steiner N; Ionită I; Zaharia CN; Petrescu A; Ciocîrlie I; Stafie D; Dicu A; Stanciu A; Muşat G
    Rev Roum Virol; 1992; 43(1-2):47-58. PubMed ID: 1283825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting.
    Buonagurio DA; O'Neill RE; Shutyak L; D'Arco GA; Bechert TM; Kazachkov Y; Wang HP; DeStefano J; Coelingh KL; August M; Parks CL; Zamb TJ; Sidhu MS; Udem SA
    Virology; 2006 Apr; 347(2):296-306. PubMed ID: 16413592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
    N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.